Krzystolik MG - Search Results

1

Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.

Li E, Donati S, Lindsley KB, Krzystolik MG, Virgili G. Li E, et al. Among authors: krzystolik mg. Cochrane Database Syst Rev. 2020 May 5;5(5):CD012208. doi: 10.1002/14651858.CD012208.pub2. Cochrane Database Syst Rev. 2020. PMID: 32374423 Free PMC article.

2

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Solomon SD, et al. Among authors: krzystolik mg. Cochrane Database Syst Rev. 2014 Aug 29;8(8):CD005139. doi: 10.1002/14651858.CD005139.pub3. Cochrane Database Syst Rev. 2014. PMID: 25170575 Free PMC article. Review.

3

Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review.

Solomon SD, Lindsley KB, Krzystolik MG, Vedula SS, Hawkins BS. Solomon SD, et al. Among authors: krzystolik mg. Ophthalmology. 2016 Jan;123(1):70-77.e1. doi: 10.1016/j.ophtha.2015.09.002. Epub 2015 Oct 21. Ophthalmology. 2016. PMID: 26477843 Free PMC article. Review.

4

Cost and Selection of Ophthalmic Anti-Vascular Endothelial Growth Factor Agents.

Li E, Greenberg PB, Voruganti I, Krzystolik MG. Li E, et al. Among authors: krzystolik mg. R I Med J (2013). 2016 May 2;99(5):15-7. R I Med J (2013). 2016. PMID: 27128510 Review.

5

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Solomon SD, et al. Among authors: krzystolik mg. Cochrane Database Syst Rev. 2019 Mar 4;3(3):CD005139. doi: 10.1002/14651858.CD005139.pub4. Cochrane Database Syst Rev. 2019. PMID: 30834517 Free PMC article.

6

Nurse-administered intravitreal injections: a systematic review.

Li E, Greenberg PB, Krzystolik MG. Li E, et al. Among authors: krzystolik mg. Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1619-21. doi: 10.1007/s00417-014-2921-y. Epub 2015 Jan 15. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25588804 Review. No abstract available.

7

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.

Vedula SS, Krzystolik MG. Vedula SS, et al. Among authors: krzystolik mg. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005139. doi: 10.1002/14651858.CD005139.pub2. Cochrane Database Syst Rev. 2008. PMID: 18425911 Free PMC article. Updated. Review.

8

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study.

Friberg TR, Tolentino M; LEVEL Study Group; Weber P, Patel S, Campbell S, Goldbaum M. Friberg TR, et al. Br J Ophthalmol. 2010 Dec;94(12):1611-7. doi: 10.1136/bjo.2009.174946. Epub 2010 May 14. Br J Ophthalmol. 2010. PMID: 20472746 Free PMC article. Clinical Trial.

9

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O'Neill CA, Miller JW. Krzystolik MG, et al. Arch Ophthalmol. 2002 Mar;120(3):338-46. doi: 10.1001/archopht.120.3.338. Arch Ophthalmol. 2002. PMID: 11879138

10

Observational study of subclinical diabetic macular edema.

Diabetic Retinopathy Clinical Research Network; Bressler NM, Miller KM, Beck RW, Bressler SB, Glassman AR, Kitchens JW, Melia M, Schlossman DK. Diabetic Retinopathy Clinical Research Network, et al. Eye (Lond). 2012 Jun;26(6):833-40. doi: 10.1038/eye.2012.53. Epub 2012 Mar 23. Eye (Lond). 2012. PMID: 22441027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page